TATRC Tech-Watch Weekly
A weekly collection of COVID-19 focused Telemedicine articles, emerging technologies, clinical guidelines, and workflows from across industry, academia, medical research, and government. Brought to you by the USAMRDC's Telemedicine & Advanced Technology Research Center.
Week of April 4-10, 2021
Medical trials are risky business. Human subjects eager to help researchers find cures or treatments for life-threatening ailments put their trust in medical professionals. But what if these trials could be conducted without human testers?
Pilot project demonstrates how drones can improve access to health care
The University of Cincinnati has invented a new telehealth drone to improve access to medical services regardless of location.
Inventors Victoria Wangia-Anderson, Manish Kumar, Seung-Yeon Lee and Debi Sampsel from three colleges at UC collaborated to develop a semi-autonomous prototype that can be dispatched right to people’s homes
Treating a patient in person versus on video requires some adjustments. For Dr. Amy Crawford-Faucher, it wasn’t just about changing the questions she asked but also the subtle cues she looked for.
The U.S. military has seen a surge in the use of virtual medical care, as patients avoid doctor’s offices and health care workers work to minimize their exposure to the coronavirus.
Human error is an inevitable event in the practice of any trade, including healthcare and medicine. The errors made in medicine can have many negative effects for patients and healthcare providers.
Fort McCoy’s medical training facilities have a busy training season ahead teaching the Soldiers who help their teammates recover from illness or injury.
Fort McCoy has two medical training facilities: the Medical Simulation Training Center (MSTC) and Regional Training Site (RTS)-Medical.
The views, opinions and/or findings contained in these articles are those of the author and do not necessarily reflect the views of the Department of Defense and should not be construed as an official DoD/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made. Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the U.S. Government.